Oncodesign Company
%20.jpg)
Oncodesign develops anticancer therapies for the treatment of patients with cancer.
Last Funding Type:
Venture - Series Unknown
Funding Status:
IPO
Headquarters:
Others
Founded Date:
1995-01-01
Investor Type:
For Profit
Total Funding:
$29.4M
Technology:
Precision Medicine
Employee Number:
101-250
Estimated Revenue:
$1M to $10M
Investors Number:
3
Industry:
P4 Medicine